121 related articles for article (PubMed ID: 29286128)
1. Protection against monocrotaline-induced pulmonary arterial hypertension and caveolin-1 downregulation by fluvastatin in rats.
Zhu S; Wang J; Wang X; Zhao J
Mol Med Rep; 2018 Mar; 17(3):3944-3950. PubMed ID: 29286128
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of cold-inducible RNA-binding protein exacerbated monocrotaline-induced pulmonary artery hypertension through Caveolin1 and CAVIN1.
Liu J; Ke X; Wang L; Zhang Y; Yang J
J Cell Mol Med; 2021 May; 25(10):4732-4743. PubMed ID: 33755319
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
Li XL; Guan RJ; Li JJ
J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
[TBL] [Abstract][Full Text] [Related]
4. Continuous fluoxetine administration prevents recurrence of pulmonary arterial hypertension and prolongs survival in rats.
Zhu SP; Mao ZF; Huang J; Wang JY
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):e1-5. PubMed ID: 19473340
[TBL] [Abstract][Full Text] [Related]
5. Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
Sahara M; Sata M; Morita T; Hirata Y; Nagai R
PLoS One; 2012; 7(3):e33367. PubMed ID: 22479390
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
[TBL] [Abstract][Full Text] [Related]
7. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
[TBL] [Abstract][Full Text] [Related]
8. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline.
Qin T; Kong B; Dai C; Xiao Z; Fang J; Shuai W; Huang H
Bioengineered; 2022 Feb; 13(2):2697-2709. PubMed ID: 35042435
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
[TBL] [Abstract][Full Text] [Related]
11. Involvement of S100A4/Mts1 and associated proteins in the protective effect of fluoxetine against MCT - Induced pulmonary hypertension in rats.
Song ZH; Wang HM; Liu M; Bai Y; Wang Y; Wang HL
J Chin Med Assoc; 2018 Dec; 81(12):1077-1087. PubMed ID: 30031694
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
13. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
14. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of common signal transduction pathways affected by rBMSCs/F92A-Cav1 in the lungs of rat with pulmonary arterial hypertension.
Chen H; Yang H; Xu C; Yue H; Xia P; Strappe PM; Wang L; Pan L; Tang W; Chen S; Wang L
Biomed Pharmacother; 2016 Oct; 83():100-106. PubMed ID: 27470556
[TBL] [Abstract][Full Text] [Related]
16. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
17. Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats.
Bi LQ; Zhu R; Kong H; Wu SL; Li N; Zuo XR; Zhou SM; Kou JP; Yu BY; Wang H; Xie WP
Int Immunopharmacol; 2013 May; 16(1):7-16. PubMed ID: 23538027
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stem Cells Expressing eNOS and a Cav1 Mutant Inhibit Vascular Smooth Muscle Cell Proliferation in a Rat Model of Pulmonary Hypertension.
Chen H; Yang H; Yue H; Strappe PM; Xia P; Pan L; Zhang Y; Chai S; Chen S; Ma L; Wang L
Heart Lung Circ; 2017 May; 26(5):509-518. PubMed ID: 27771236
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of vesicular transport proteins in pulmonary arterial hypertension in monocrotaline-treated rats.
Zhang H; Luo Q; Liu Z; Wang Y; Zhao Z
Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):156-63. PubMed ID: 25630652
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats.
Sun X; Ku DD
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H801-9. PubMed ID: 18055512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]